Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
Stock Summary
Top 10 Correlated Stocks
285130.KS
Financial details
Company Rating
Strong Buy
Market Cap
1800.67B
Income
148.23B
Revenue
2194.62B
Book val./share
64693.28
Cash/share
-
Dividend
3400
Dividend %
3.37%
Employees
1.42K
Optionable
No
Shortable
Yes
Earnings
14 Nov 2022
P/E
21.41
Forward P/E
-
PEG
-3.17
P/S
1.45
P/B
1.56
P/C
-
P/FCF
-54.78
Quick Ratio
-
Current Ratio
2.73
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
4.19K
EPS next Y
-
EPS next Q
-
EPS this Y
-58.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
88.49%
Revenue Q/Q
19.89%
EPS Q/Q
22.99%
-
-
-
-
SMA20
2.73%
SMA50
4.78%
SMA100
-18.01%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
7%
ROC
0.19%
Gross Margin
41%
Oper. Margin
24%
Profit Margin
7%
Payout
72%
Shs Outstand
17.23M
Shs Float
12.83M
-
-
-
-
Target Price
-
52W Range
87400.0-228666.67
52W High
-55.83%
52W Low
+15.56%
RSI
46.12
Rel Volume
0.76
Avg Volume
71.35K
Volume
54.58K
Perf Week
-3.81%
Perf Month
-5.16%
Perf Quarter
-25.74%
Perf Half Y
-18.55%
-
-
-
-
Beta
1.44444
-
-
Volatility
1708.32%, 3851.59%
Prev Close
-3.81%
Price
101000
Change
-2.42%
Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 4.49K | 78.82K | 81.55K | 69.04K | 66.5K | |
| Net income per share | -436.67 | 347.38 | 605.56 | 14.46K | 5.35K | |
| Operating cash flow per share | -545.76 | 3.88K | 6.98K | 14.04K | 16.21K | |
| Free cash flow per share | -995.42 | -987.13 | -440.27 | 8.52K | 11.53K | |
| Cash per share | 7.94K | 10.41K | 15.58K | 24.25K | 65.24K | |
| Book value per share | 35.63K | 39.87K | 40.89K | 54.16K | 65.36K | |
| Tangible book value per share | 34.99K | 39.6K | 38.93K | 52.4K | 80.27K | |
| Share holders equity per share | 35.63K | 39.87K | 40.89K | 54.16K | 65.36K | |
| Interest debt per share | 45.56K | 54.58K | 66.49K | 41.66K | 15.83K | |
| Market cap | 1505.18B | 786.67B | 707.01B | 4937.95B | 3943.34B | |
| Enterprise value | 2238.25B | 1656.83B | 1653.42B | 5559.81B | 4174.45B | |
| P/E ratio | -176.34 | 130.5 | 66.72 | 19.42 | 23.45 | |
| Price to sales ratio | 17.14 | 0.58 | 0.5 | 4.07 | 1.89 | |
| POCF ratio | -141.09 | 11.68 | 5.79 | 19.99 | 7.74 | |
| PFCF ratio | -77.35 | -45.92 | -91.76 | 32.95 | 10.89 | |
| P/B Ratio | 2.16 | 1.14 | 0.99 | 5.18 | 1.92 | |
| PTB ratio | 2.16 | 1.14 | 0.99 | 5.18 | 1.92 | |
| EV to sales | 25.48 | 1.21 | 1.16 | 4.58 | 2 | |
| Enterprise value over EBITDA | -1.47K | 11.21 | 10.06 | 14.37 | 9.5 | |
| EV to operating cash flow | -209.8 | 24.59 | 13.54 | 22.51 | 8.2 | |
| EV to free cash flow | -115.03 | -96.72 | -214.59 | 37.1 | 11.53 | |
| Earnings yield | -0.01 | 0.01 | 0.01 | 0.05 | 0.04 | |
| Free cash flow yield | -0.01 | -0.02 | -0.01 | 0.03 | 0.09 | |
| Debt to equity | 0.69 | 0.85 | 0.95 | 0.53 | 0.13 | |
| Debt to assets | 0.62 | 0.63 | 0.66 | 0.55 | 0.35 | |
| Net debt to EBITDA | -480.65 | 5.89 | 5.76 | 1.61 | 0.53 | |
| Current ratio | 1 | 1.21 | 1.1 | 1.43 | 2.56 | |
| Interest coverage | -3.97 | 1.44 | 2.41 | 4.36 | 52.39 | |
| Income quality | 1.25 | 11.18 | 11.52 | 0.97 | 3.03 | |
| Dividend Yield | 0 | 0 | 0.01 | 0 | 0.01 | |
| Payout ratio | 0 | 0 | 0.5 | 0.02 | 0.16 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0.05 | 0.04 | 0.05 | 0.05 | 0.04 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Capex to operating cash flow | 0.82 | -1.25 | -1.06 | -0.39 | -0.29 | |
| Capex to revenue | -0.1 | -0.06 | -0.09 | -0.08 | -0.07 | |
| Capex to depreciation | -1.19 | -0.95 | -1.26 | -0.99 | -1.58 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 18.71K | 17.65K | 23.6K | 132.72K | 88.71K | |
| ROIC | -0.01 | 0.03 | 0.06 | 0.07 | 0.19 | |
| Return on tangible assets | 0 | 0 | 0.01 | 0.12 | 0.04 | |
| Graham Net | -45.06K | -50.72K | -55.72K | -34.55K | 26.59K | |
| Working capital | 1.68B | 122.86B | 73.16B | 277.61B | 1697.41B | |
| Tangible asset value | 683.97B | 687.22B | 681.28B | 921.98B | 2522.32B | |
| Net current asset value | -518.48B | -508.08B | -620.98B | -237.75B | 1395.16B | |
| Invested capital | 1.28 | 1.32 | 1.58 | 0.74 | 0.24 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 118.96B | 117.22B | 114.79B | 83.73B | 125.94B | |
| Average inventory | 271.6B | 290.94B | 291.77B | 252.93B | 301.11B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 748.95 | 50.23 | 48.35 | 35.36 | 50.8 | |
| Days of inventory on hand | 1.41K | 109.62 | 109.58 | 106.8 | 105.52 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0.49 | 7.27 | 7.55 | 10.32 | 7.19 | |
| Inventory turnover | 0.26 | 3.33 | 3.33 | 3.42 | 3.46 | |
| ROE | -0.01 | 0.01 | 0.01 | 0.27 | 0.08 | |
| Capex per share | -449.65 | -4.87K | -7.42K | -5.52K | -4.68K |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q2
| Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 22.25K | 26.98K | 23.8K | 13.31K | 15.95K | |
| Net income per share | 2.67K | -1.4K | 2.97K | 1.17K | 1.44K | |
| Operating cash flow per share | -1.07K | 2.84K | 10.67K | -6.34K | -1.45K | |
| Free cash flow per share | -2.95K | 744.52 | 9.27K | -7.75K | -3.83K | |
| Cash per share | 86.92K | 87.54K | 65.24K | 0 | 0 | |
| Book value per share | 101.79K | 100.74K | 65.36K | 64.53K | 64.69K | |
| Tangible book value per share | 121.49K | 121.75K | 80.27K | 81.21K | 82.01K | |
| Share holders equity per share | 101.79K | 100.74K | 65.36K | 64.53K | 64.69K | |
| Interest debt per share | 25.61K | 25.6K | 15.46K | 325.69 | -188.02 | |
| Market cap | 3394.87B | 3701.01B | 4681.73B | 4273.26B | 2893.87B | |
| Enterprise value | 3705.46B | 3995.49B | 4912.84B | 4273.26B | 2893.87B | |
| P/E ratio | 16.23 | -33.92 | 12.53 | 29.02 | 15.98 | |
| Price to sales ratio | 7.79 | 7.02 | 6.26 | 10.22 | 5.77 | |
| POCF ratio | -162.62 | 66.62 | 13.96 | -21.44 | -63.41 | |
| PFCF ratio | -58.69 | 254.3 | 16.07 | -17.56 | -24.03 | |
| P/B Ratio | 1.7 | 1.88 | 2.28 | 2.11 | 1.42 | |
| PTB ratio | 1.7 | 1.88 | 2.28 | 2.11 | 1.42 | |
| EV to sales | 8.5 | 7.57 | 6.57 | 10.22 | 5.77 | |
| Enterprise value over EBITDA | 37.16 | 2.73K | 20.39 | 52.16 | 50.23 | |
| EV to operating cash flow | -177.5 | 71.92 | 14.65 | -21.44 | -63.41 | |
| EV to free cash flow | -64.06 | 274.54 | 16.86 | -17.56 | -24.03 | |
| Earnings yield | 0.02 | -0.01 | 0.02 | 0.01 | 0.02 | |
| Free cash flow yield | -0.02 | 0 | 0.06 | -0.06 | -0.04 | |
| Debt to equity | 0.2 | 0.18 | 0.13 | 0 | 0 | |
| Debt to assets | 0.34 | 0.35 | 0.35 | 0.31 | 0.3 | |
| Net debt to EBITDA | 3.11 | 201.18 | 0.96 | 0 | 0 | |
| Current ratio | 2.9 | 2.7 | 2.56 | 2.99 | 2.73 | |
| Interest coverage | 24.25 | 29.4 | -308.63 | 4.76 | -14.76 | |
| Income quality | -0.4 | -2.04 | 3.59 | -5.41 | -1.01 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.21 | 0.19 | |
| Research and developement to revenue | 0.04 | 0.05 | 0.03 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0 | 0 | |
| Capex to operating cash flow | 1.77 | -0.74 | -0.13 | 0.22 | 1.64 | |
| Capex to revenue | -0.08 | -0.08 | -0.06 | -0.11 | -0.15 | |
| Capex to depreciation | -1.55 | -1.64 | -2.1 | -2 | -3.3 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 78.21K | 56.24K | 66.12K | 41.24K | 45.8K | |
| ROIC | 0.03 | 0.04 | 0.1 | 0.02 | 0.03 | |
| Return on tangible assets | 0.01 | -0.01 | 0.02 | 0.01 | 0.01 | |
| Graham Net | 29.93K | 28.94K | 26.59K | -36.91K | -35.8K | |
| Working capital | 1612.69B | 1632.52B | 1697.41B | 1678.27B | 1565.51B | |
| Tangible asset value | 2379.52B | 2379.97B | 2522.32B | 0 | 0 | |
| Net current asset value | 1194.78B | 1262.95B | 1395.16B | 1361.39B | 1344.98B | |
| Invested capital | 0.25 | 0.25 | 0.24 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 43.53 | 49.8 | 40.94 | 0 | 0 | |
| Days of inventory on hand | 97.67 | 101.95 | 85.05 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 2.07 | 1.81 | 2.2 | 0 | 0 | |
| Inventory turnover | 0.92 | 0.88 | 1.06 | 0 | 0 | |
| ROE | 0.03 | -0.01 | 0.05 | 0.02 | 0.02 | |
| Capex per share | -1.89K | -2.1K | -1.4K | -1.4K | -2.38K |
Frequently Asked Questions
What is SK Chemicals Co.,Ltd. stock symbol ?
SK Chemicals Co.,Ltd. is a US stock and trading under the symbol 285130.KS
What is SK Chemicals Co.,Ltd. stock quote today ?
SK Chemicals Co.,Ltd. stock price is $101000 today.
Is SK Chemicals Co.,Ltd. stock public?
Yes, SK Chemicals Co.,Ltd. is a publicly traded company.
Company Profile
- Volume Average 71.35K
- Market Capitalization 1800.67B
- Employee 1.42K
- Headquarters Seongnam-si,US
- IPO Date 2018-01-10
-
Website
https://www.skchemicals.com 
SK Chemicals Co., Ltd. provides chemicals and life sciences products and solutions in South Korea and internationally. The company develops copolysters, coating and adhesive materials, engineering plastics, prepergs, bio materials, and 3D printing materials, as well as specialty chemicals, pharmaceutical products, and vaccines. It has a collaborate agreement with Standigm, Inc. to develop an AI-driven drug candidate for non-alcoholic steatohepatitis. The company was founded in 1969 and is headquartered in Seongnam, South Korea.
